Evaluation of a patient decision aid for BRCA1/2 pathogenic variant carriers choosing an ovarian cancer prevention strategy

M.P. Steenbeek, M.H.D. van Bommel*, M.G. Harmsen, N. Hoogerbrugge, H.C. van Doorn, J.H.M. Keurentjes, M. van Beurden, R.P. Zweemer, K.N. Gaarenstroom, C.G.J. Penders, M.M.A. Brood-van Zanten, M.C. Vos, J.M. Piek, L.R.C.W. van Lonkhuijzen, M.J.A. Apperloo, S.F.P.J. Coppus, J. IntHout, J.A. de Hullu, R.P.M.G. Hermens

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)371-377
Number of pages7
JournalGynecologic Oncology
Volume163
Issue number2
DOIs
Publication statusPublished - 1 Nov 2021

Keywords

  • Decision aid
  • BRCA
  • Ovarian cancer
  • Risk-reducing salpingo-oophorectomy
  • Salpingectomy
  • BRCA1/2 MUTATION CARRIERS
  • RISK-REDUCING SURGERY
  • RANDOMIZED-TRIAL
  • SALPINGO-OOPHORECTOMY
  • BREAST-CANCER
  • WOMEN
  • ASSOCIATION
  • VALIDATION
  • DISTRESS
  • SURVIVAL

Cite this